MX2021014577A - Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb. - Google Patents
Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb.Info
- Publication number
- MX2021014577A MX2021014577A MX2021014577A MX2021014577A MX2021014577A MX 2021014577 A MX2021014577 A MX 2021014577A MX 2021014577 A MX2021014577 A MX 2021014577A MX 2021014577 A MX2021014577 A MX 2021014577A MX 2021014577 A MX2021014577 A MX 2021014577A
- Authority
- MX
- Mexico
- Prior art keywords
- azepanes
- fluoro
- capsid assembly
- hbv capsid
- assembly modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se divulgan compuestos, composiciones y métodos para tratar enfermedades, síndromes, afecciones y trastornos que se ven afectados por la modulación de CAM1; tales compuestos se representan mediante la Fórmula (I) tal como sigue: (ver fórmula) en donde R1a, R1b, R2 , R3 , R4 y X se definen en la presente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962853554P | 2019-05-28 | 2019-05-28 | |
PCT/EP2020/064747 WO2020239862A1 (en) | 2019-05-28 | 2020-05-27 | Di-fluoro azepanes as hbv capsid assembly modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014577A true MX2021014577A (es) | 2022-03-17 |
Family
ID=70968928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014577A MX2021014577A (es) | 2019-05-28 | 2020-05-27 | Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220235051A1 (es) |
EP (1) | EP3976614A1 (es) |
JP (1) | JP2022534247A (es) |
KR (1) | KR20220012320A (es) |
CN (1) | CN113939511A (es) |
AU (1) | AU2020281803A1 (es) |
BR (1) | BR112021023456A2 (es) |
CA (1) | CA3138159A1 (es) |
MX (1) | MX2021014577A (es) |
WO (1) | WO2020239862A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6713465B2 (ja) * | 2014-12-30 | 2020-06-24 | ノヴィラ・セラピューティクス・インコーポレイテッド | B型肝炎感染症治療のための誘導体及び方法 |
EP3478683B1 (en) * | 2016-06-29 | 2021-07-21 | Novira Therapeutics Inc. | Diazepinone derivatives and their use in the treatment of hepatitis b infections |
-
2020
- 2020-05-27 US US17/595,612 patent/US20220235051A1/en active Pending
- 2020-05-27 CN CN202080039612.5A patent/CN113939511A/zh active Pending
- 2020-05-27 JP JP2021570273A patent/JP2022534247A/ja active Pending
- 2020-05-27 MX MX2021014577A patent/MX2021014577A/es unknown
- 2020-05-27 KR KR1020217042049A patent/KR20220012320A/ko unknown
- 2020-05-27 AU AU2020281803A patent/AU2020281803A1/en not_active Abandoned
- 2020-05-27 BR BR112021023456A patent/BR112021023456A2/pt not_active Application Discontinuation
- 2020-05-27 CA CA3138159A patent/CA3138159A1/en active Pending
- 2020-05-27 WO PCT/EP2020/064747 patent/WO2020239862A1/en unknown
- 2020-05-27 EP EP20729987.6A patent/EP3976614A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2020239862A1 (en) | 2020-12-03 |
AU2020281803A1 (en) | 2021-11-25 |
BR112021023456A2 (pt) | 2022-01-18 |
US20220235051A1 (en) | 2022-07-28 |
CA3138159A1 (en) | 2020-12-03 |
JP2022534247A (ja) | 2022-07-28 |
EP3976614A1 (en) | 2022-04-06 |
CN113939511A (zh) | 2022-01-14 |
KR20220012320A (ko) | 2022-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022005827A (es) | Derivados de pirazol como inhibidores de malt1. | |
MX2021014350A (es) | Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos. | |
CR20210592A (es) | Moduladores de la vía integrada del estrés | |
MX2021013193A (es) | Cicloalquilos sustituidos como moduladores de la vía integrada del estrés. | |
CR20220363A (es) | Compuestos tricíclicos sustituidos | |
PH12020552207A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
MX2021012706A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
MX2020006290A (es) | Dinucleotidos ciclicos como agonistas de sting. | |
JO2853B1 (en) | Sulfonamides as TRPM8 organizations | |
PH12020551327A1 (en) | Compounds | |
MX2021009521A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
GEP20156239B (en) | Benzofuranyl derivatives used as glucokinase inhibitors | |
MX2021008400A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
PH12020552206A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
MX2022003166A (es) | Moduladores de il-17a y usos de los mismos. | |
MX2019005934A (es) | Compuestos de benzodiazolio como inhibidores del canal de sodio epitelial (enac). | |
PH12020552172A1 (en) | Cyclic dinucleotides as sting agonists | |
EA202190272A1 (ru) | Дополнительно замещенные производные триазолохиноксалина | |
MX2020012281A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. | |
EA202190271A1 (ru) | Замещенные триазолохиноксалиновые производные | |
CR20220004A (es) | Nuevos compuestos heterocíclicos | |
MX2023005928A (es) | Moduladores de malt-1. | |
SA520420046B1 (ar) | مركبات بيريدازينون ثلاثية الحلقة مندمجة وعقاقير أولية منها مفيدة لعلاج الإصابات الفيروسة المخاطية القويمة | |
MX2021012417A (es) | Anillos de piridina que contienen derivados como inhibidores de malt1. | |
MX2022002470A (es) | Inhibidores de dihidroorotato deshidrogenasa sustituidos con urea. |